Skip to main content
ADPT logo
ADPT
(NASDAQ)
Adaptive Biotechnologies Corporation
$24.34-- (--)
Loading... - Market loading

Adaptive Biotechnologies (ADPT) Stock Price & Financial Analysis

Adaptive Biotechnologies Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$23.62 - $24.60
52-Week High$26.87
52-Week Low$12.00
Open$23.98
Volume1.36M
Average Volume (3M)2.18M
Market Cap3.88B
Shares Outstanding159.86M
Price to Sales (P/S)12.60
Price to Book (P/B)25.76
EV/EBITDA-184.90
Revenue (TTM)308.08M
Net Income (TTM)-63.85M
Free Cash Flow (TTM)-29.54M
EPS (TTM)$-0.40
Profit Margin-20.73%
Operating Margin-12.16%
Return on Equity (ROE)-42.38%
Debt to Equity2.22
50-Day MA$23.53
200-Day MA$17.74
52-Week Change94.10%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Adaptive Biotechnologies

What is the current stock price for ADPT?

As of the latest trading session, ADPT stock trades at $24.34. The 52-week range is $12.00–$26.87, with a day range of $23.62–$24.60.

What is the P/E ratio for ADPT?

The P/E ratio (Price-to-Earnings) for ADPT is shown in the Key Statistics section. This valuation metric helps compare Adaptive Biotechnologies Corporation to industry peers.

Does ADPT pay dividends?

Adaptive Biotechnologies does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ADPT?

Based on 7 analysts, the consensus for ADPT is Buy.

What is the market cap of ADPT?

Adaptive Biotechnologies's market capitalization is $3.89B, classifying it as a mid-cap company. Adaptive Biotechnologies operates in the Healthcare sector within the Diagnostics & Research industry.